Transepithelial photorefractive keratectomy without mitomycin-C for irregular astigmatism after femtosecond laser-assisted in situ keratomileusisflap complications  

作　　者：Ning-Na Zhang Li-Ming Tao Jing Wang 

机构地区：[1]Department of Ophthalmology,The Second Affiliated Hospital of Anhui Medical University,Hefei 230000,Anhui Province,China

出　　处：《International Journal of Ophthalmology(English edition)》2024年第6期1168-1170,共3页国际眼科杂志（英文版）

基　　金：Supported by Colleges and Universities Provincial Quality Engineering Project of Anhui Provincial Department(No.2021jyxm0711);2021 Scientific Research Project of Anhui Provincial Health Commission(No.AHWJ2021b115);Scientific Research Foundation of Anhui Medical University(No.2022xkj189);Anhui Provincial Scientific Research Program(No.2022AH050792);2020 Clinical Research Cultivation Program of the Second Affiliated Hospital of Anhui Medical University(No.2020LCZD09).

摘　　要：Dear Editor,W e write to present a case report of transepithelial photorefractive keratectomy(TPRK)without mitomycin-C(MMC)for irregular astigmatism after femtosecond laser-assisted in situ keratomileusis(FS-LASIK)flap complications.Written informed consent was obtained from the patient to allow the publication of this case and associated accompanying images.The study was conducted in accordance with the Helsinki Declaration.TPRK is a surgical procedure which uses an excimer laser to ablation of both the corneal epithelium and stroma,which is widely used in clinic[1-2].The procedure may be conducted in cases where there is notable topographic irregularity or scarring following complications with the LASIK flap.Corneal haze is a potential complication following TPRK,and the use of MMC as a prophylactic agent against postoperative corneal haze has been demonstrated to significantly reduce its formation after TPRK/photorefractive keratectomy(PRK).

关 键 词：COMPLICATIONS MITOMYCIN EPITHELIUM 

分 类 号：R779.6[医药卫生—眼科]